Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction (2019)
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: ANGIOTENSINAS, DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA CARDÍACA, HIPOTENSÃO
ABNT
SOLOMON, S. D. et al. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. The New England Journal of Medicine, v. 381, n. 17, p. 1609-1620, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1908655. Acesso em: 06 nov. 2024.APA
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., et al. (2019). Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. The New England Journal of Medicine, 381( 17), 1609-1620. doi:10.1056/NEJMoa1908655NLM
Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Simões MV. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction [Internet]. The New England Journal of Medicine. 2019 ; 381( 17): 1609-1620.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1056/NEJMoa1908655Vancouver
Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Simões MV. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction [Internet]. The New England Journal of Medicine. 2019 ; 381( 17): 1609-1620.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1056/NEJMoa1908655